The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy ; volume:9 ; number:1 ; day:6 ; month:1 ; year:2021 ; pages:1-17 ; date:12.2021
Acta Neuropathologica Communications ; 9, Heft 1 (6.1.2021), 1-17, 12.2021
- Creator
-
Scaglioni, Dominic
Catapano, Francesco
Ellis, Matthew
Torelli, Silvia
Chambers, Darren
Feng, Lucy
Beck, Matthew
Sewry, Caroline
Monforte, Mauro
Harriman, Shawn
Koenig, Erica
Malhotra, Jyoti
Popplewell, Linda
Guglieri, Michela
Straub, Volker
Mercuri, Eugenio
Servais, Laurent
Phadke, Rahul
Morgan, Jennifer
Muntoni, Francesco
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-020-01106-1
- URN
-
urn:nbn:de:101:1-2021020803204194326696
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scaglioni, Dominic
- Catapano, Francesco
- Ellis, Matthew
- Torelli, Silvia
- Chambers, Darren
- Feng, Lucy
- Beck, Matthew
- Sewry, Caroline
- Monforte, Mauro
- Harriman, Shawn
- Koenig, Erica
- Malhotra, Jyoti
- Popplewell, Linda
- Guglieri, Michela
- Straub, Volker
- Mercuri, Eugenio
- Servais, Laurent
- Phadke, Rahul
- Morgan, Jennifer
- Muntoni, Francesco
- SpringerLink (Online service)
Other Objects (12)
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
Survival in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model
Vascular-targeted therapies for Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Left ventricular noncompaction in Duchenne muscular dystrophy
Strategies for molecular therapy of Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
Survival in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model
Vascular-targeted therapies for Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Left ventricular noncompaction in Duchenne muscular dystrophy
Strategies for molecular therapy of Duchenne muscular dystrophy
Left ventricular T2 distribution in Duchenne Muscular Dystrophy
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
Survival in Duchenne muscular dystrophy
Targeting angiogenesis in Duchenne muscular dystrophy
Pain characterization in Duchenne muscular dystrophy
Cognition trajectory in Duchenne muscular dystrophy
Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model
Vascular-targeted therapies for Duchenne muscular dystrophy
The Duchenne muscular dystrophy gene and cancer
Left ventricular noncompaction in Duchenne muscular dystrophy
Strategies for molecular therapy of Duchenne muscular dystrophy